Literature DB >> 8968742

Homozygous and compound heterozygous mutations at the Werner syndrome locus.

J Oshima1, C E Yu, C Piussan, G Klein, J Jabkowski, S Balci, T Miki, J Nakura, T Ogihara, J Ells, M Smith, M I Melaragno, M Fraccaro, S Scappaticci, J Matthews, S Ouais, A Jarzebowicz, G D Schellenberg, G M Martin.   

Abstract

The Werner syndrome (WS) is a rare autosomal recessive progeroid disorder. The Werner syndrome gene (WRN) has recently been identified as a member of the helicase family. Four distinct mutations were previously reported in three Japanese and one Syrian WS pedigrees. The latter mutation was originally described as a 4 bp deletion spanning a spliced junction. It is now shown that this mutation results in a 4 bp deletion at the beginning of an exon. Nine new WRN mutations in 10 additional WS patients, both Japanese and Caucasian, are described. These include three compound heterozygotes (one Japanese and two Caucasian). The new mutations are located all across the coding region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968742     DOI: 10.1093/hmg/5.12.1909

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  25 in total

1.  WRN mutations in Werner syndrome patients: genomic rearrangements, unusual intronic mutations and ethnic-specific alterations.

Authors:  Katrin Friedrich; Lin Lee; Dru F Leistritz; Gudrun Nürnberg; Bidisha Saha; Fuki M Hisama; Daniel K Eyman; Davor Lessel; Peter Nürnberg; Chumei Li; María J Garcia-F-Villalta; Carolien M Kets; Joerg Schmidtke; Vítor Tedim Cruz; Peter C Van den Akker; Joseph Boak; Dincy Peter; Goli Compoginis; Kivanc Cefle; Sukru Ozturk; Norberto López; Theda Wessel; Martin Poot; P F Ippel; Birgit Groff-Kellermann; Holger Hoehn; George M Martin; Christian Kubisch; Junko Oshima
Journal:  Hum Genet       Date:  2010-05-05       Impact factor: 4.132

Review 2.  The Werner mutation: does it lead to a "public" or "private" mechanism of aging?

Authors:  G M Martin
Journal:  Mol Med       Date:  1997-06       Impact factor: 6.354

Review 3.  Genetics and the pathobiology of ageing.

Authors:  G M Martin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

4.  Human RECQ Helicase Pathogenic Variants, Population Variation and "Missing" Diseases.

Authors:  Wenqing Fu; Alessio Ligabue; Kai J Rogers; Joshua M Akey; Raymond J Monnat
Journal:  Hum Mutat       Date:  2016-12-09       Impact factor: 4.878

Review 5.  The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis.

Authors:  Meltem Muftuoglu; Junko Oshima; Cayetano von Kobbe; Wen-Hsing Cheng; Dru F Leistritz; Vilhelm A Bohr
Journal:  Hum Genet       Date:  2008-09-23       Impact factor: 4.132

6.  Mechanism of Werner DNA helicase: POT1 and RPA stimulates WRN to unwind beyond gaps in the translocating strand.

Authors:  Byungchan Ahn; Jae Wan Lee; Hana Jung; Gad Beck; Vilhelm A Bohr
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

7.  Mutant huntingtin impairs Ku70-mediated DNA repair.

Authors:  Yasushi Enokido; Takuya Tamura; Hikaru Ito; Anup Arumughan; Akihiko Komuro; Hiroki Shiwaku; Masaki Sone; Raphaele Foulle; Hirohide Sawada; Hiroshi Ishiguro; Tetsuya Ono; Miho Murata; Ichiro Kanazawa; Nikolai Tomilin; Kazuhiko Tagawa; Erich E Wanker; Hitoshi Okazawa
Journal:  J Cell Biol       Date:  2010-05-03       Impact factor: 10.539

8.  Nucleolar localization of the Werner syndrome protein in human cells.

Authors:  R A Marciniak; D B Lombard; F B Johnson; L Guarente
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Characterization of Werner syndrome protein DNA helicase activity: directionality, substrate dependence and stimulation by replication protein A.

Authors:  J C Shen; M D Gray; J Oshima; L A Loeb
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

10.  Werner syndrome gene variants in human sarcomas.

Authors:  Jessica J Hsu; Ashwini S Kamath-Loeb; Eitan Glick; Brett Wallden; Karen Swisshelm; Brian P Rubin; Lawrence A Loeb
Journal:  Mol Carcinog       Date:  2010-02       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.